Literature DB >> 23929268

Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.

Renu Virk1, Shweta Shinagare2, Gregory Y Lauwers3, Vijay Yajnik4, John H Stone5, Vikram Deshpande3.   

Abstract

The distinction of Crohn's disease from ulcerative colitis is based on clinical, endoscopic, radiological, and histological findings, a paradigm that remains unchanged despite the advent of new understanding of the immunological and genetic basis of inflammatory bowel disease. There is a strong correlation between inflammatory bowel disease, predominantly ulcerative colitis, and autoimmune pancreatitis. We hypothesized that colonic biopsies from patients with inflammatory bowel disease would demonstrate increased numbers of IgG4-positive plasma cells and that this elevation might be restricted to ulcerative colitis. We examined a cohort of 78 cases of inflammatory bowel disease: 50 ulcerative colitis and 38 Crohn's disease. We identified treatment-naive biopsies. Additionally, four cases of inflammatory bowel disease associated with autoimmune pancreatitis and 15 cases of lymphocytic/collagenous colitis were also identified. Immunohistochemical stains for IgG4 were performed. Biopsies from patients with ulcerative colitis showed significantly higher numbers of IgG4-bearing plasma cells than those with Crohn's disease (mean IgG4 counts per high-power field (hpf) 9.8 vs 2.8, P=0.001). Samples from 19 (38%) ulcerative colitis patients had IgG4 counts >10/hpf, compared with only two (5%) patients with Crohn's disease; the sensitivity and specificity of a cutoff at 10 IgG4-positive plasma cells per hpf was 38 and 95%, respectively. Among individuals <18 years, there were no statistically differences in the IgG4 counts between the two subforms of inflammatory bowel disease. Among adult patients, a cutoff of 5 IgG4+ plasma cells distinguished ulcerative colitis from Crohn's disease with a sensitivity of 53% and specificity of 83%. In comparison to inflammatory bowel disease, patients with lymphocytic/collagenous colitis showed significantly lower numbers of IgG4-positive plasma cells (P=0.0001). Ulcerative colitis with pancolitis showed higher numbers of IgG4-bearing plasma cells (mean IgG4 12.8 vs 5.8 per hpf; P=0.09). An immunohistochemical stain for IgG4 may aid in making the distinction between ulcerative colitis and Crohn's disease (with exclusion of the pediatric cases), albeit with a relatively low sensitivity. This study also provides additional support to the hypothesis that a subset of ulcerative colitis cases is associated with a Th2 response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929268     DOI: 10.1038/modpathol.2013.121

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  6 in total

Review 1.  IgG4-related disease: a new kid on the block or an old aquaintance?

Authors:  Georg Beyer; Theresa Schwaiger; Markus M Lerch; Julia Mayerle
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Hepatic nodular lymphoid lesion with increased IgG4-positive plasma cells associated with primary biliary cirrhosis: a report of two cases.

Authors:  Jessica Calvo; Nicolas Carbonell; Olivier Scatton; Christophe Marzac; Nathalie Ganne-Carrie; Dominique Wendum
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

3.  Can IgG4 Levels Identify the Ulcerative Colitis Subtype of Inflammatory Bowel Disease?

Authors:  Ricardo Jacaranda Faria; Cintia Mendes Clemente; Fabiana P Carneiro; Leopoldo Santos-Neto
Journal:  Gastroenterology Res       Date:  2015-04-03

4.  Pancreatic endosonographic findings and clinical correlation in Crohn's disease.

Authors:  Éverson Fernando Malluta; Fauze Maluf-Filho; André Zonetti de Arruda Leite; Carmen Lucia Ortiz-Agostinho; Iêda Nishitokukado; Adriana Ribas Andrade; Maria Laura Lacava Lordello; Fabiana Maria Dos Santos; Aytan Miranda Sipahi
Journal:  Clinics (Sao Paulo)       Date:  2019-05-30       Impact factor: 2.365

5.  Reduced CD27-IgD- B Cells in Blood and Raised CD27-IgD- B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease.

Authors:  Chathyan Pararasa; Na Zhang; Thomas J Tull; Ming H A Chong; Jacqueline H Y Siu; William Guesdon; Konstantia Maria Chavele; Jeremy D Sanderson; Louise Langmead; Klaartje Kok; Jo Spencer; Anna Vossenkamper
Journal:  Front Immunol       Date:  2019-03-05       Impact factor: 7.561

6.  High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease.

Authors:  Zhujun Wang; Min Zhu; Chengxin Luo; Yu Zhen; Jingxi Mu; Wenyan Zhang; Qin Ouyang; Hu Zhang
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.